Professor Andreas Baumbach

Chair for Device Innovation
Centre: Cardiovascular Medicine and Devices
Email: a.baumbach@qmul.ac.uk Telephone: +44(0) 203 765 8740
Profile
Professor Andreas Baumbach is active in coronary and structural intervention, and has published extensively in the field of interventional research covering preclinical, first in man, pivotal and post market studies. He has an interest in device innovation and regulatory pathways.
Professor Baumbach has a strong commitment to training and education. He is on the board of directors of the largest interventional congress EuroPCR and PCR London Valves. He is past President of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Research
Group members
Prof Christos Bourantas, Dr Anantharam Ramasary, Dr Nida Ahmed, Dr Ratesh Bajaj, Dr Kush Patel
Summary
Active in first in human trials, as well as large scale multinational, multi-centre randomised clinical trial evaluation of novel devices.
Publications
-
Daros CB, Stevenson A, Patel K et al. (2026). Impact of first myocardial infarction on the right ventricle: a magnetic resonance-based assessment. nameOfConference
QMRO: qmroHref -
Bajaj R, Huang X, Alves-Kotzev N et al. (2026). Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology. nameOfConference
DOI: 10.1093/cvr/cvaf281
-
He X, Bransby KM, Ulutas AE et al. (2026). A novel framework for fully automated co-registration of intravascular ultrasound and optical coherence tomography imaging data. nameOfConference
-
He X, Mohamed MO, Ng NYJ et al. (2026). A deep learning methodology for fully-automated quantification of calcific burden in high-resolution intravascular ultrasound images. nameOfConference
-
Patel KP, Baumbach A (2025). Pioneering Treatment for Aortic Regurgitation. nameOfConference
-
Serruys PW, Tobe A, van Royen N et al. (2026). 1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis The LANDMARK Trial. nameOfConference
-
Tsai T, Wykrzykowska J, Lansky A et al. (2025). 12- vs. 1-month DAPT: comparative outcomes after aspirin cessation with HT supreme stent. nameOfConference
QMRO: qmroHref -
Oshima A, Tsai T, Wykrzykowska J et al. (2025). The EAPCI device success algorithm in the PIONEER IV trial: insights with angiography-derived FFR. nameOfConference
QMRO: qmroHref -
Yap NAL, He X, Tanboga IH et al. (2025). Implications of computed tomography reconstruction algorithms on coronary atheroma composition: A head-to-head comparison with multimodality near-infrared spectroscopy intravascular ultrasound imaging. nameOfConference
-
Sivananthan A, S M TK, Tanboga IH et al. (2025). Deep-learning analysis of computed tomography coronary angiography data enables more accurate computation of the shear stress distribution than conventional analysis by experts: A head-to-head comparison with near-infrared spectroscopy-intravascular ultrasound-based modelling. nameOfConference
Collaborators
External
- Meril Life
- Jenavalve
- Microport
Disclosures
- Institutional Research Support: Abbott Vascular
- Consultation and Speaker Fees: Astra Zeneca, Sinomed, Microport, Medtronic, Faraday Pi-Cardia, Biosensors, Jenavalve